Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Catherine Longworth

Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!

Advertisement
Set Alert for Articles By Catherine Longworth

Latest From Catherine Longworth

Q3 Earnings Spotlight: Roche, Abbott, bioMérieux Lead IVD Company Results

Medtech Insight highlights Q3 2018 results from some of the leading IVD players. In this edition, we spotlight some of the big companies including Roche Diagnostics, Thermo Fisher Scientific, bioMérieux, and Becton Dickinson.

Commercial In Vitro Diagnostics

Medtech Money Flow: M&A And VC Deals, Oct. 29-Nov. 4, 2018

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, between Oct. 29 and Nov. 4, 2018.  

M & A Financing

Device Week, Nov. 2, 2018 – Third-Quarter Earnings Report Update From IVD, Cardio, and Ortho Companies

On this week's podcast, Reed Miller and Catherine Longworth give an overview of the third-quarter earnings reports from the major public companies in the in vitro diagnostics, cardiovascular and orthopedics device sectors.

Device Week Business Strategies

Emerging Technologies: French Fish For Marine-Derived Therapies

The French region of Brittany is emerging as a leading area for the development of biotech derived from marine resources, with nearly 70 enterprises currently active across the region. Key players assembled at the bi-annual SeaTech Week held in Brest to discuss how marine bioresources can inspire a new wave of health-care innovation.

Emerging Markets Innovation

Medtech Money Flow: M&A And VC Deals, Oct. 22-28, 2018

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, between Oct. 22 and Oct. 28.   
M & A Deals

Glycotest Attracts $10M Chinese Investment For Liver Disease Test

Liver-diagnostics firm Glycotest has secured a $10m investment from Chinese healthcare group Shanghai Fosun Pharmaceutical (Fosun Pharma) to drive commercialization of its HCC Panel test for early-stage liver cancer.

Financing Liver & Hepatic
See All
Advertisement
UsernamePublicRestriction

Register